migraine5

Study Information 

The World Health Organization places migraine and migraine headaches as one of the 10 most disabling medical illnesses on Earth.  Migraine impact over 37 million men, women and children in the United States alone.  For more than 90 percent of those affected, migraine interferes with education, career or social activities.  In 2018, the FDA approved four preventive treatments designed specifically for migraine.  However, there are still ongoing and upcoming clinical research studies to advance migraine prevention and treatment.

 

The Study:

AMR Lexington is currently enrolling volunteers ages 18 to 75 in an investigational migraine clinical study.

 

Qualified participants must: 

  • be diagnosed with Episodic Migraine
  • have a history of migraine headaches of at least one year
  • meet other study criteria

Qualified participants will receive at no cost: 

  • all study-related care
  • lab tests
  • investigational medication or placebo

Compensation is available for time and travel. Insurance is not required. 

For more information or to see if you qualify, call 859-264-8999 or fill out the form below. 

If you are interested in participating in this study, please fill out the form below.  We will contact you within 48 hours to follow up and clarify any questions that you, or we, may have.  Per AMR Lexington’s privacy policy, all your personal information that we have obtained will be kept in our secure database, which can only be accessed by authorized AMR Lexington personnel, unless given your permission or except as required by law.

By submitting this information, AMR Lexington has my permission to contact me.  My consent allows AMR Lexington to use phone, text, and email messages to contact me.  Message and data rates may apply.  I may contact AMR Lexington at any time to change these preferences. To be removed or to change your contact preferences, please call an AMR Lexington recruitment specialist at 859-264-8999.

×

Make an appointment and we’ll contact you.